Blog - Page 882 of 5699 - QualityStocks

WednesdaySep 21, 2022 12:07 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced its participation in upcoming conferences taking place in September and October 2022. The company’s CEO Doug Drysdale participated in a panel discussion titled “Trials to Treatments” at the Interdisciplinary Conference on Psychedelic Research, Psychedelic Science, Ethics & Business Event in Haarlem, Amsterdam. The announcement includes further details on additional conferences and the participation schedule for Drysdale and additional members of Cybin’s management team in panel discussions and presentations. The additional events include the Interdisciplinary Conference on Psychedelic Research, Sept. 22-24,…

WednesdaySep 21, 2022 12:00 pm

REZYFi Inc. Addresses Loan Needs of Growing Cannabis Industry Through Subsidiary Companies: REZYFi Lending and ResMac Inc.

The global cannabis market is expected to reach $33 billion by 2025, driven by legality and regulation within the market REZYFi is servicing the needs of both traditional and non-traditional consumers and businesses Company targets licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing REZYFi’s management team is leveraging its extensive industry experiences in real estate, finance and cannabis to pursue company objectives The cannabis industry has experienced significant growth in recent years due to the expanding legalization and…

WednesdaySep 21, 2022 11:34 am

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering

Aditxt Inc. (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has closed on its recent public offering. The offering was comprised of 3,333,333 shares of common stock or common stock equivalents; the offering also included warrants to purchase up to 3,333,333 shares of common stock. The combined offering price to the public was $6 per share and associated warrant, with the warrants, which are exercisable upon being issued, having an exercise price of $6 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, which resulted…

WednesdaySep 21, 2022 11:25 am

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Take the Spotlight with a Robot Show in Sterling, Virginia

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at 22895 Ladbrook Drive in Sterling, Virginia, on Sept. 20-21, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow has made 56 landings in 22 states and Washington, D.C., to date. Knightscope’s crime-fighting robots tour the U.S. in a space-age, NASA-like ‘pod’ allowing attendees to experience all the technology that is enabling…

WednesdaySep 21, 2022 11:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Launches Pre-Sale Order Process for Green Ammonia Modules Capable of Securing Farm Fuel Supply

Canadian clean energy and fertilizer innovator FuelPositive Corp. has launched its pre-sale application process for its long-awaited onsite, containerized green ammonia production system, capable of providing nitrogen fertilizer for a 2,000-acre farm The system is designed to deliver a solution to farmers’ dependence on uncertain supplies of fertilizer, as well as to eliminate the carbon emissions associated with the production of fertilizer In Europe, a number of large ammonia producers have severely reduced their supply as gas prices continue to soar as a consequence of Russia’s war on Ukraine and the industry’s dependence on Russian gas The reduction of European…

WednesdaySep 21, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Expands Renewable Energy Industry Reach by Entering Northeast Market

Correlate recently announced its letter of intent to acquire Vermont-based Aegis Renewable Energy and plans to use its deep regulatory knowledge, project fulfillment and operations and maintenance capabilities to deliver on and expand its project backlog in the region Correlate is at the forefront of creating industry-leading energy solutions and financing platforms for commercial and industrial sectors The portfolio for energy optimization is a $290 billion market, driving deep financial savings and energy efficiency across the commercial sector Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for all of North America, is expanding its…

WednesdaySep 21, 2022 9:45 am

GeoSolar Technologies Inc. Positioned to Benefit from Biden Administration Plans to Expand Geothermal Technology

U.S. Department of Energy recently announced Biden administration plans to reduce geothermal system costs by 90% to $45 per megawatt hour by 2035 GeoSolar’s SmartGreen(R) residential and commercial energy systems leverage solar and geothermal energy to dramatically lower or eliminate utility bills Additional SmartGreen(R) system customizations include tightening building envelope, insulation upgrades, LED lighting replacement, EV charging infrastructure The U.S. Department of Energy (“DOE”) recently announced that the Biden administration plans to reduce geothermal system costs by 90% to $45 per megawatt hour by 2035 (https://nnw.fm/JJHUW). Increased awareness and mainstream adoption of the technology will likely benefit Colorado-based GeoSolar Technologies…

WednesdaySep 21, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Provide Bioavailable Oral Treatment for Hypertension, Mitigate Effects of High Blood Pressure

Lexaria is a biotechnology company pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”) The company has developed the patented DehydraTECH(TM) drug delivery technology, which has been shown to deliver more API at a faster rate than controls Lexaria’s DehydraTECH pipeline includes DehydraTECH-CBD for the treatment of hypertension Through pre-clinical studies, DehydraTECH-CBD has been shown to decrease systolic blood pressure among hypertensive volunteers The company intends to file an Investigational New Drug (“IND”) application and has already received confirmation that the FDA agrees with its proposed abbreviated pathway under section 501(b)(2) Oral…

TuesdaySep 20, 2022 3:19 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases New Video Exploring Its Technologies, Progress of AIMIGo(TM) Device

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. The company today announced that, in conjunction with its upcoming virtual roadshow webinar taking place at 4:30 p.m. ET on Tuesday, Sept. 20, 2022, it has released a new video that takes viewers behind the scenes for a featured look at the HeartBeam AIMIGo technology. “This new video provides a compelling overview and explanation of our technologies and highlights our continued progress toward making the AIMIGo device available for remote heart attack detection,” said Branislav Vajdic,…

TuesdaySep 20, 2022 2:26 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Hypertension Drug Market with Proprietary Drug-Delivery Method

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is focused on establishing a stronghold in the $28 billion hypertension drug market. The company’s exclusive therapeutic, DehydraTECH-CBD, has shown exciting potential as an alternative to traditional cannabidiol (“CBD”) dosing methods; the proprietary treatment may offer improved and more rapid absorption of drugs into the bloodstream and brain. According to the announcement, only one FDA-approved CBD drug is currently available on the market; that drug is for pediatric epilepsy. Lexaria is working to offer the second-ever, FDA-approved CBD therapeutic, designed to treat hypertension. The market for the treatment is tremendous,…

Site Search

Company Search